To what extent is Art important to scientists?
Maya Shah is the School Competition’s Year 12-13 category winner, and discusses whether or not art is important to scientists.
Continue reading
The Future of Science is Like Rice on a Chess Board
Hemlata Pant is the Schools Competition Year 10-11 category winner, and discusses the exponential growth of scientific knowledge.
Frankenstein: A monster who saved lives
Mridul Shrestha discusses the relationship between science and science fiction, taking the example of Mary Shelley’s Frankenstein.
Does the discovery of a ‘chronic pain gene’ solve the complexities of treating the disease?
Chronic pain diseases continue to cause distress worldwide and are now the leading cause of disability. Benjamin Fisher discusses why we can experience chronic pain, how it is researched and new findings that provide a source of hope for chronic pain sufferers.
The Oxford Scientist Trinity Term 2022: NETWORKS
Everything around us is constantly interacting. We spend most of our lives connecting with others, exchanging words or thoughts, conveying pieces of
ourselves and our experiences. Our social networks and relationships define us to the extent that we become increasingly more similar to the people we interact
with.
The Oxford Scientist Hilary Term 2022: REGENERATION
We’re in a time of transition, awakening and rebirth. As we
are emerging from the pandemic and move onto the next chapter, we’re filled with hope to tackle
new challenges.
Reimagining Dinosaurs
Our perception of dinosaurs is changing. Peyton Cherry discusses how recent scientific evidence is helping us to reimaging what our favourite dinosaurs looked like and how they lived.
Is there a cure for long COVID?
New research shows that more than 2 million people in the UK are now suffering from long COVID. Megan Perry discusses what might be causing the condition and how scientists are trying to cure it.
Innate-like T-cells: a New Weapon in Cancer Immunotherapy?
New research has found a novel population of T-cells that may be more successful than current immunotherapy treatments at targeting cancer cells. James O’Brien discusses.
Can we control the power of the human genome?
Max Cowan explores the possibilities created by human genome sequencing and the considerations that need to be put in place for its widespread and commercial use.